214.50USDMkt Cap: 378.98B USDP/E: 105.15Last update: 2026-05-21
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimm…
Industry Peers
Drug Manufacturers - Generalloading…
Indicators:|
Key Statistics
Company
Market Cap378.98B USD
Enterprise Value442.54B USD
Revenue (TTM)62.82B USD
Gross Profit42.96B USD
Net Income (TTM)4.23B USD
Revenue/Share35.50 USD
Last Price214.50 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees57.0K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISINUS00287Y1091
Valuation
P/E (Trailing)105.15
P/E (Forward)13.22
PEG0.59
EV/EBITDA14.79
EV/Revenue7.04
P/S6.03
P/B-56.94
EPS (TTM)2.04
EPS (Forward)16.23
52W Range
209.5081% of range215.64
52W High215.64 USD
52W Low209.50 USD
Profitability
Gross Margin70.24%
Oper. Margin32.16%
EBITDA Margin47.62%
Profit Margin6.91%
ROE-129.24%
ROA3.15%
Growth
Revenue Growth12.40%
Earnings Growth-46.20%
Cash Flow & Leverage
Operating CF19.03B USD
CapEx (TTM)1.21B USD
FCF Margin33.13%
FCF Yield5.49%
Net Debt63.52B USD
Net Debt/EBITDA2.12
Balance Sheet
Debt/Equity-20.64
Current Ratio0.80
Quick Ratio0.52
Book Value/Sh-3.7670 USD
Cash/Share5.315 USD
Dividends
Fwd Div Rate6.920 USD
Trail. Div Rate6.740 USD
Div. Yield3.23%
5Y Avg Yield3.62%
Payout Ratio325.98%
Ex-Div DateApr 15, 2026
Pay DateMay 15, 2026
Analyst Consensus
Rating1.8 (Buy)
Target (Mean)252.90 USD
Target Range184.00 USD – 328.00 USD
# Analysts29
Ownership
Shares Out.1.77B
Float1.76B
Insiders0.11%
Institutions77.04%
Short Interest
Short Ratio3.0d
Short % Float1.32%
Short % Out.1.18%
Shares Short20.91M
Short (prev mo.)20.13M
Technical
SMA 50208.51 (+2.9%)
SMA 200219.14 (-2.1%)
Beta0.30
S&P 52W Chg28.31%
Avg Vol (30d)2.67M
Avg Vol (10d)5.42M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—